Shaping the platform
A senior representative from each of our industry partners sits on the Company Partner Forum. This key group advises the executive team, ensuring that our technology development meets the needs of those conducting clinical trials for dementia.
The power of networks
We recognise that the connections between researchers in universities and scientists in industry is the key way to accelerate research into effective prevention and treatments for dementia. As members of our research communities, industry scientists are able to leverage the power of our networks, developing innovative studies that crosscut traditional boundaries.
-
Jenny Barnett
Cambridge Cognition
-
Roger Gunn
Invicro
-
Declan Jones
Janssen Pharmaceuticals
-
David MacAllan
Somalogic
-
Robert Neal
GlaxoSmithKline
-
Michael Perkinton
AstraZeneca
-
Robin Wolz
Ixico
